Q: Is the goal of Tirzepatide to treat obesity long-term
( 2 ) For people struggling with obesity or excess weight, these effects can lead to: Reduced appetite and cravings Eating smaller portion sizes without feeling deprived More stable blood sugar, which can help curb energy crashes A gradual, steady loss of body fat over time While GLP-1 medications were first approved for diabetes management, researchers soon noticed that many patients taking the medication experienced significant weight loss as a side effect
The serious adverse events associated with these medications, documented internationally through FDA safety communications and incident reports, have consistently occurred in the context of unsupervised use
A FAERS database analysis of suicidal tendencies associated with GLP-1 RAs showed disproportionate reports of suicidal ideation and depression/suicide for semaglutide and liraglutide, but no disproportionate signals for suicidal behavior, attempted suicide, or suicide death across all FDA-approved GLP-1 RAs [Reference McIntyre, Mansur, Rosenblat and Kwan48]